Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Classification of ethmoid malignancies]

G Cantù1, N Pizzi, F Mattavelli

  • 1Sezione di Chirurgia Cranio-Maxillo-Facciale, Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano.

Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|February 2, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective study with Comprehensive Geriatric Assessment (CGA) before curative treatment in older patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).

Oral oncology·2026
Same author

Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouse.

ESMO real world data and digital oncology·2026
Same author

Medical decision analysis for personalized oncology at the patient bedside.

Tumori·2026
Same author

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: <i>post hoc</i> insights from the C-POST and KEYNOTE-630 studies.

Immuno-oncology technology·2026
Same author

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

ESMO open·2026
Same author

Corrigendum to "Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival" Eur J Cancer 229 (October) (2025) 115692.

European journal of cancer (Oxford, England : 1990)·2025

This study introduces a new classification for ethmoid malignancies, identifying key prognostic factors like dural and intradural extension. The new staging system accurately predicts outcomes, with survival rates decreasing significantly from T2 to T4 stages.

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Pathology

Context:

  • Ethmoid malignancies lack a standardized classification system, hindering accurate prognostication.
  • Previous classifications often focused on single histological types or limited extension patterns.
  • The Union for International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC) lacked comprehensive staging for ethmoid tumors before 1997.

Purpose:

  • To develop and validate a new classification system for ethmoid malignancies.
  • To identify and incorporate critical prognostic factors, including intracranial and orbital invasion.
  • To correlate tumor stage with patient survival outcomes after craniofacial resection.

Summary:

  • A review of 84 patients with ethmoid malignancies treated with anterior craniofacial resection between 1987 and 1994.

Related Experiment Videos

  • A novel classification was applied, considering factors like dura invasion, intradural extension, and invasion of adjacent sinuses and fossae.
  • Disease-free survival at 36 months showed a clear decline with increasing tumor stage (T2: 54%, T3: 41%, T4: 8%), particularly in previously untreated patients (T2: 63%, T3: 45%, T4: 9%).

    • Impact:

    • The proposed classification effectively identifies key prognostic indicators for ethmoid malignancies.
    • This staging system provides a more accurate basis for predicting patient outcomes and guiding treatment strategies.
    • The findings support the identified prognostic factors as crucial for understanding the behavior of ethmoid tumors.